NDC 48433-314-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48433-314
- Requested NDC
- 48433-314-01
- Package NDCs from labels
- 48433-314-01, 48433-314-10
- Manufacturer
- Safecor Health, LLC
- Effective date
- 2012-06-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Safecor Health, LLC | Safecor Health, LLC | 2012-06-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | FUROSEMIDE TABLET [SAFECOR HEALTH, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSEMIDE | FUROSEMIDE | Aurobindo Pharma Limited | a504ee4b-3995-45f2-898c-91116dd81d19 | 2025-07-19 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 3ba730ab-90d4-478a-80b3-1ea3edb03e4d | 2025-07-15 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | NorthStar Rx LLC | fc3194a3-7e75-4551-8334-4a5cc22d9f8b | 2025-07-07 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Proficient Rx LP | 600ca175-be2b-4c43-b119-133ae21a5601 | 2025-07-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Baxter Healthcare Corporation | c71371a7-75c5-45b8-b762-8d782d4c71bc | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Sagent Pharmaceuticals | d76bd85a-8e57-477e-9607-c9435f1e26fb | 2025-06-26 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Solco Healthcare LLC | 6a0fb397-63ae-4fce-bddf-16a91b1b7a2f | 2025-06-18 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Maiva Pharma Private Limited | e5880bf4-5037-4813-b7cc-656a6832ecb5 | 2025-06-13 | Warnings | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Prefferred Pharmaceuticals Inc. | ede9846b-b4c5-4be2-9188-fd65e66cd893 | 2025-04-30 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Coupler LLC | 33ec71e2-8fbd-0703-e063-6294a90a62e1 | 2025-04-29 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Chartwell RX, LLC | 8ebd2f10-acfc-48a4-a5db-f20377bda9ce | 2025-03-26 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Hikma Pharmaceuticals USA Inc. | ddfc41a9-37d4-49c1-bbf3-969a98cd649c | 2025-03-10 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Avenacy Inc. | 7d0db0f7-bf4f-4b0b-9359-2a838626e04b | 2025-02-28 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Rising Pharma Holdings, Inc. | 6101b9b4-f3ef-438e-a857-b4ea55ffc679 | 2025-02-21 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Camber Pharmaceuticals, Inc. | f6221cce-e586-4002-bd14-6ec22eb14e2e | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Ipca Laboratories Limited | 0acd293b-ecab-4879-a8e7-cd1b76148f2a | 2025-01-20 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 809d9734-12dd-3b1f-e053-2a91aa0aadee | 2025-01-02 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 813c8e9b-61bc-27c4-e053-2a91aa0a9f45 | 2024-12-26 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | c794c95a-654e-48fe-9596-201fc122ff75 | 2024-12-09 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | 3747bbcd-783d-4baa-bb5b-b6827bf390e3 | 2024-12-09 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.